Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kanithra Sekaran"'
Publikováno v:
Leukemia & Lymphoma. 63:1669-1677
In multiple myeloma (MM), it is unclear whether early and late responders to daratumumab have similar outcomes. We pooled individual-level data from phase 3 trials and divided them into early and late response groups based on median time to response.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48a176d1fac954bf6f511edf08b6d59
https://doi.org/10.1080/10428194.2022.2038376
https://doi.org/10.1080/10428194.2022.2038376
Autor:
Jiasheng Wang, Srilatha Dasari, Michael Daunov, Kanithra Sekaran, Yeseong Kim, Brenda W. Cooper
Publikováno v:
Blood. 140:9889-9890
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0f1fe1556489b4d68b7f5767cc184b5
https://doi.org/10.1182/blood-2022-167875
https://doi.org/10.1182/blood-2022-167875
Autor:
Bhamini Patel, Peter Hopmann, Mansee Desai, Kanithra Sekaran, Kathleen Graham, Liya Yin, William Chilian
Publikováno v:
Physiologic and Pathologic Angiogenesis-Signaling Mechanisms and Targeted Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c4fc2bc8eab60f4dc359d38d4578bc
http://www.intechopen.com/articles/show/title/coronary-collateral-growth-clinical-perspectives-and-recent-insights
http://www.intechopen.com/articles/show/title/coronary-collateral-growth-clinical-perspectives-and-recent-insights
